Steve Sandor has over 20 years of experience specializing in therapeutics market access, government healthcare policy, pricing and reimbursement. Steve has held various leadership roles for large U.S. and global pharmaceutical manufactures. Prior to joining Paratek Pharmaceuticals in 2017, Steve was the Vice President of Market Access and Policy at Acorda Therapeutics where he led the Payer Account Team and was responsible for pricing, contracting and payer strategy for the entire Acorda product portfolio. Before joining Acorda, he was the Vice President of Market Access and HEOR at Piramal Molecular Imaging, Global Market Access Leader for GE Healthcare, Executive Director of Managed Healthcare Marketing for Forest Laboratories where he led a team responsible for payer strategy, pricing and contracting for the company’s first hospital antibiotic, and Director of Customer Planning and Contracting at Hoffmann-La Roche. Steve’s prior experience also includes ownership in a start-up specialty pharmacy where he held the position as Principal for 9 years. Steve received his undergraduate degree at the University of Maryland, Masters of Business Administration, School of Banking and Money Management at Adelphi University and his Jurist Doctorate at Elisabeth Haub School of Law at Pace University. In addition, Steve was awarded a certificate in Health Law Policy from Pace Law School and is a licensed attorney in the State of New Jersey.